AU2002307327A1 - Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes - Google Patents

Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes

Info

Publication number: AU2002307327A1
Authority: AU; Australia
Prior art keywords: diabetes; medicament; manufacture; treatment; type
Prior art date: 2001-05-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002307327A

Other languages

English (en)

Inventor

Emanuele Sher

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-04

Filing date

2002-04-22

Publication date

2002-11-18

2002-04-22 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

2002-11-18 Publication of AU2002307327A1 publication Critical patent/AU2002307327A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

AU2002307327A 2001-05-04 2002-04-22 Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes Abandoned AU2002307327A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US28889101P	2001-05-04	2001-05-04
US60/288,891		2001-05-04
PCT/US2002/011847 WO2002089848A2 (fr)	2001-05-04	2002-04-22	Methode de traitement du diabete

Publications (1)

Publication Number	Publication Date
AU2002307327A1 true AU2002307327A1 (en)	2002-11-18

Family

ID=23109101

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002307327A Abandoned AU2002307327A1 (en)	2001-05-04	2002-04-22	Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes

Country Status (5)

Country	Link
EP (1)	EP1390072A2 (fr)
JP (1)	JP2004530680A (fr)
AU (1)	AU2002307327A1 (fr)
CA (1)	CA2446161A1 (fr)
WO (1)	WO2002089848A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5014334B2 (ja) *	2005-10-06	2012-08-29	イーライリリーアンドカンパニー	Ａｍｐａ受容体増強剤
DE102008047461A1 (de) *	2008-09-17	2010-04-15	Dr.Ing.H.C.F.Porsche Aktiengesellschaft	Verbindungseinrichtung zum Verbinden von Verkleidungselementen
PL389364A1 (pl)	2009-10-23	2011-04-26	Uniwersytet Jagielloński	Nowe zastosowanie pochodnych 2-pirolidonu
CA2915405A1 (fr) *	2013-06-13	2014-12-18	Veroscience Llc	Compositions et methodes pour le traitement des troubles metaboliques
DK3573611T3 (da) *	2017-01-24	2022-04-11	Alphala Co Ltd	Amidforbindelser og anvendelse deraf

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2703051B1 (fr) *	1993-03-26	1995-04-28	Adir	Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
WO1998011892A1 (fr) *	1996-09-17	1998-03-26	The Regents Of The University Of California	Modulation positive du recepteur ampa permettant d'ameliorer l'expression des facteurs neurotrophiques dans le cerveau
GB9702194D0 (en) *	1997-02-04	1997-03-26	Lilly Co Eli	Sulphonide derivatives
PE20000943A1 (es) *	1998-07-31	2000-09-28	Lilly Co Eli	Derivados de sulfonamida
DE69917278T2 (de) *	1998-07-31	2005-05-19	Eli Lilly And Co., Indianapolis	Heterocyclyl sulphonamid derivate
ATE374747T1 (de) *	1999-04-30	2007-10-15	Lilly Co Eli	Monofluoralkylderivate
WO2001042203A1 (fr) *	1999-12-08	2001-06-14	Eli Lilly And Company	Derives de sulfonamide de cyclopentyle
WO2001089510A2 (fr) *	2000-05-24	2001-11-29	Eli Lilly And Company	Methode de traitement de l'obesite

2002
- 2002-04-22 CA CA002446161A patent/CA2446161A1/fr not_active Abandoned
- 2002-04-22 EP EP02769268A patent/EP1390072A2/fr not_active Withdrawn
- 2002-04-22 WO PCT/US2002/011847 patent/WO2002089848A2/fr not_active Ceased
- 2002-04-22 AU AU2002307327A patent/AU2002307327A1/en not_active Abandoned
- 2002-04-22 JP JP2002586980A patent/JP2004530680A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
JP2004530680A (ja)	2004-10-07
EP1390072A2 (fr)	2004-02-25
WO2002089848A2 (fr)	2002-11-14
CA2446161A1 (fr)	2002-11-14
WO2002089848A3 (fr)	2002-12-12

Similar Documents

Publication	Publication Date	Title
AU2180400A (en)	2000-08-01	A pharmaceutical combination for the treatment of depression
AU2002348332A1 (en)	2003-05-19	Customized physiological monitor
AU2002342050A1 (en)	2003-04-22	Anesthesia drug monitor
AU4612300A (en)	2001-05-10	Preventive or therapeutic drugs for diabetes
AU2002249111A1 (en)	2002-08-28	Process for the preparation of a medical implant
AU2001276860A1 (en)	2002-01-30	Medicaments for chemotherapeutic treatment of disease
AU2002253039A1 (en)	2003-02-27	Tramadol-based medicament
AU2002338303A1 (en)	2002-10-28	Therapeutic compositions for the treatment of a respiratory tract disease
AU2002353739A1 (en)	2003-06-10	Therapeutic compounds
IL162853A0 (en)	2005-11-20	The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus
AU2002307327A1 (en)	2002-11-18	Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes
AU2002336437A1 (en)	2003-03-10	Therapeutic uses of complement receptor 2
AU2003209542A1 (en)	2003-09-22	Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
AU2002327440A1 (en)	2003-03-10	Treatment of type i diabetes
GB0212790D0 (en)	2002-07-10	Medicament for the treatment of diabetes
AU3071899A (en)	1999-09-20	Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
AU2003242538A1 (en)	2003-11-11	Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug
AU2002348105A1 (en)	2003-05-12	Oral dosage forms for improving the bioavailability of therapeutic agents
AU2001261023A1 (en)	2001-12-03	Use of an ampa receptor potentiator for the treatment of obesity
AU2003232698A1 (en)	2003-10-20	Use of a n,n'-dibenzyl-thiourea as medicine
AU2003214317A1 (en)	2003-07-30	Use of a novel class of drugs for the treatment of parasitic diseases
AU2002309243A1 (en)	2002-10-03	Heterocyclic compounds for therapeutic use
HK1069107A (en)	2005-05-13	The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus
AU1271801A (en)	2001-04-23	Use of (r)-zacopride or a salt thereof for the manufacture of a medicament for the treatment of sleep apnea
AU2002258223A1 (en)	2002-12-16	Drugs for diabetes

Legal Events

Date	Code	Title	Description
2004-02-19	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase